Adaptive clinical trial designs for phase I cancer studies (Q2452091): Difference between revisions

From MaRDI portal
ReferenceBot (talk | contribs)
Changed an Item
Set OpenAlex properties.
 
Property / OpenAlex ID
 
Property / OpenAlex ID: W1975592428 / rank
 
Normal rank

Latest revision as of 10:00, 30 July 2024

scientific article
Language Label Description Also known as
English
Adaptive clinical trial designs for phase I cancer studies
scientific article

    Statements

    Adaptive clinical trial designs for phase I cancer studies (English)
    0 references
    0 references
    0 references
    0 references
    30 May 2014
    0 references
    Bayesian designs
    0 references
    ``best intention'' designs
    0 references
    continual reassessment method
    0 references
    dose finding studies
    0 references
    estimation efficiency
    0 references
    ethics
    0 references
    maximum tolerated dose
    0 references
    oncology trial designs
    0 references
    optimal designs
    0 references
    phase I
    0 references
    stochastic approximation
    0 references
    toxicity
    0 references
    up-and-down designs
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references